Core Laboratories Inc. earnings per share and revenue
On Oct 22, 2025, CLB reported earnings of 0.22 USD per share (EPS) for Q3 25, beating the estimate of 0.19 USD, resulting in a 12.88% surprise. Revenue reached 134.52 million, compared to an expected 132.61 million, with a 1.44% difference. The market reacted with a +28.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.19 USD, with revenue projected to reach 132.41 million USD, implying an decrease of -13.64% EPS, and decrease of -1.57% in Revenue from the last quarter.
FAQ
What were Core Laboratories Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Core Laboratories Inc. reported EPS of $0.22, beating estimates by 12.88%, and revenue of $134.52M, 1.44% above expectations.
How did the market react to Core Laboratories Inc.'s Q3 2025 earnings?
The stock price moved up 28.82%, changed from $12.77 before the earnings release to $16.45 the day after.
When is Core Laboratories Inc. expected to report next?
The next earning report is scheduled for Jan 29, 2026.
What are the forecasts for Core Laboratories Inc.'s next earnings report?
Based on 4
analysts, Core Laboratories Inc. is expected to report EPS of $0.19 and revenue of $132.41M for Q4 2025.